The current price of 3360.T is ¥2,527.50 — it has increased by 3.08% since the previous close. Data as of Nov 5, 2026.
3360.T is up 0.62% over the past week, up 2.97% over the past month and up 9.72% over the past year. The price is above its 200-day moving average of ¥2,400.98.
Of the 3 analysts covering Ship Healthcare Holdings, Inc., 1 rates it a strong buy and 2 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Ship Healthcare Holdings, Inc. has a market capitalization of ¥231.65B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Ship Healthcare Holdings, Inc. posted earnings of ¥22.74 per share against an estimate of ¥27.54, missing expectations by 17.43%. Upcoming reports are listed in the earnings calendar.
Ship Healthcare Holdings, Inc. reported revenue of ¥176.36B in its most recent quarter, which has increased by 7.99% compared with the same quarter a year earlier. Analysts had expected ¥168.05B.
Yes. Ship Healthcare Holdings, Inc. pays dividends annually. The latest payment of ¥65.00 per share has a payment date of Mar 30, 2027, which corresponds to a dividend yield of 2.57%.
In the latest trading session 3360.T moved between ¥2,491.00 and ¥2,559.00, a range of 2.69% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Ship Healthcare Holdings, Inc. shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Ship Healthcare Holdings, Inc. is strong buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 3360.T has traded between ¥1,938.00 and ¥2,839.00. The current price is 10.97% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.